img

Global Live Attenuated Polio Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Live Attenuated Polio Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Live Attenuated Polio Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Live Attenuated Polio Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Live Attenuated Polio Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Live Attenuated Polio Vaccine key manufacturers include Sanofi Pasteur, GlaxoSmithKline Bio, Bilthoven Bio, Bharat Biotech and Sinovac Biotech, etc. Sanofi Pasteur, GlaxoSmithKline Bio, Bilthoven Bio are top 3 players and held % sales share in total in 2022.
Live Attenuated Polio Vaccine can be divided into Live Attenuated Vaccine and Inactivated Vaccine, etc. Live Attenuated Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Live Attenuated Polio Vaccine is widely used in various fields, such as Hospital, Clinic, Health Center and Others, etc. Hospital provides greatest supports to the Live Attenuated Polio Vaccine industry development. In 2022, global % sales of Live Attenuated Polio Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Live Attenuated Polio Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Pasteur
GlaxoSmithKline Bio
Bilthoven Bio
Bharat Biotech
Sinovac Biotech
Segment by Type
Live Attenuated Vaccine
Inactivated Vaccine

Segment by Application


Hospital
Clinic
Health Center
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Live Attenuated Polio Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Live Attenuated Polio Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Live Attenuated Polio Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Live Attenuated Polio Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Live Attenuated Polio Vaccine introduction, etc. Live Attenuated Polio Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Live Attenuated Polio Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Live Attenuated Polio Vaccine Market Overview
1.1 Live Attenuated Polio Vaccine Product Overview
1.2 Live Attenuated Polio Vaccine Market Segment by Type
1.2.1 Live Attenuated Vaccine
1.2.2 Inactivated Vaccine
1.3 Global Live Attenuated Polio Vaccine Market Size by Type
1.3.1 Global Live Attenuated Polio Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Live Attenuated Polio Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Live Attenuated Polio Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Live Attenuated Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Live Attenuated Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Live Attenuated Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Live Attenuated Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Live Attenuated Polio Vaccine Sales Breakdown by Type (2018-2024)
2 Global Live Attenuated Polio Vaccine Market Competition by Company
2.1 Global Top Players by Live Attenuated Polio Vaccine Sales (2018-2024)
2.2 Global Top Players by Live Attenuated Polio Vaccine Revenue (2018-2024)
2.3 Global Top Players by Live Attenuated Polio Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Live Attenuated Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Live Attenuated Polio Vaccine Market Competitive Situation and Trends
2.5.1 Live Attenuated Polio Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Live Attenuated Polio Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Live Attenuated Polio Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Live Attenuated Polio Vaccine Market
2.8 Key Manufacturers Live Attenuated Polio Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Live Attenuated Polio Vaccine Status and Outlook by Region
3.1 Global Live Attenuated Polio Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Live Attenuated Polio Vaccine Historic Market Size by Region
3.2.1 Global Live Attenuated Polio Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Live Attenuated Polio Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Live Attenuated Polio Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Live Attenuated Polio Vaccine Forecasted Market Size by Region
3.3.1 Global Live Attenuated Polio Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Live Attenuated Polio Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Live Attenuated Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Live Attenuated Polio Vaccine by Application
4.1 Live Attenuated Polio Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Health Center
4.1.4 Others
4.2 Global Live Attenuated Polio Vaccine Market Size by Application
4.2.1 Global Live Attenuated Polio Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Live Attenuated Polio Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Live Attenuated Polio Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Live Attenuated Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Live Attenuated Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Live Attenuated Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Live Attenuated Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Live Attenuated Polio Vaccine Sales Breakdown by Application (2018-2024)
5 North America Live Attenuated Polio Vaccine by Country
5.1 North America Live Attenuated Polio Vaccine Historic Market Size by Country
5.1.1 North America Live Attenuated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Live Attenuated Polio Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Live Attenuated Polio Vaccine Sales in Value by Country (2018-2024)
5.2 North America Live Attenuated Polio Vaccine Forecasted Market Size by Country
5.2.1 North America Live Attenuated Polio Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Live Attenuated Polio Vaccine Sales in Value by Country (2024-2029)
6 Europe Live Attenuated Polio Vaccine by Country
6.1 Europe Live Attenuated Polio Vaccine Historic Market Size by Country
6.1.1 Europe Live Attenuated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Live Attenuated Polio Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Live Attenuated Polio Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Live Attenuated Polio Vaccine Forecasted Market Size by Country
6.2.1 Europe Live Attenuated Polio Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Live Attenuated Polio Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Live Attenuated Polio Vaccine by Region
7.1 Asia-Pacific Live Attenuated Polio Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Live Attenuated Polio Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Live Attenuated Polio Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Live Attenuated Polio Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Live Attenuated Polio Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Live Attenuated Polio Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Live Attenuated Polio Vaccine Sales in Value by Region (2024-2029)
8 Latin America Live Attenuated Polio Vaccine by Country
8.1 Latin America Live Attenuated Polio Vaccine Historic Market Size by Country
8.1.1 Latin America Live Attenuated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Live Attenuated Polio Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Live Attenuated Polio Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Live Attenuated Polio Vaccine Forecasted Market Size by Country
8.2.1 Latin America Live Attenuated Polio Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Live Attenuated Polio Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Live Attenuated Polio Vaccine by Country
9.1 Middle East and Africa Live Attenuated Polio Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Live Attenuated Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Live Attenuated Polio Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Live Attenuated Polio Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Live Attenuated Polio Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Live Attenuated Polio Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Live Attenuated Polio Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pasteur Live Attenuated Polio Vaccine Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GlaxoSmithKline Bio
10.2.1 GlaxoSmithKline Bio Company Information
10.2.2 GlaxoSmithKline Bio Introduction and Business Overview
10.2.3 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Products Offered
10.2.5 GlaxoSmithKline Bio Recent Development
10.3 Bilthoven Bio
10.3.1 Bilthoven Bio Company Information
10.3.2 Bilthoven Bio Introduction and Business Overview
10.3.3 Bilthoven Bio Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bilthoven Bio Live Attenuated Polio Vaccine Products Offered
10.3.5 Bilthoven Bio Recent Development
10.4 Bharat Biotech
10.4.1 Bharat Biotech Company Information
10.4.2 Bharat Biotech Introduction and Business Overview
10.4.3 Bharat Biotech Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bharat Biotech Live Attenuated Polio Vaccine Products Offered
10.4.5 Bharat Biotech Recent Development
10.5 Sinovac Biotech
10.5.1 Sinovac Biotech Company Information
10.5.2 Sinovac Biotech Introduction and Business Overview
10.5.3 Sinovac Biotech Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sinovac Biotech Live Attenuated Polio Vaccine Products Offered
10.5.5 Sinovac Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Live Attenuated Polio Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Live Attenuated Polio Vaccine Industrial Chain Analysis
11.4 Live Attenuated Polio Vaccine Market Dynamics
11.4.1 Live Attenuated Polio Vaccine Industry Trends
11.4.2 Live Attenuated Polio Vaccine Market Drivers
11.4.3 Live Attenuated Polio Vaccine Market Challenges
11.4.4 Live Attenuated Polio Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Live Attenuated Polio Vaccine Distributors
12.3 Live Attenuated Polio Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Attenuated Vaccine
Table 2. Major Company of Inactivated Vaccine
Table 3. Global Live Attenuated Polio Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Live Attenuated Polio Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Live Attenuated Polio Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Live Attenuated Polio Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Live Attenuated Polio Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Live Attenuated Polio Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Live Attenuated Polio Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Live Attenuated Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Live Attenuated Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Live Attenuated Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Live Attenuated Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Live Attenuated Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Live Attenuated Polio Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Live Attenuated Polio Vaccine Sales Share by Company (2018-2024)
Table 26. Global Live Attenuated Polio Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Live Attenuated Polio Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Live Attenuated Polio Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Live Attenuated Polio Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Live Attenuated Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Live Attenuated Polio Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Live Attenuated Polio Vaccine Market
Table 33. Key Manufacturers Live Attenuated Polio Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Live Attenuated Polio Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Live Attenuated Polio Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Live Attenuated Polio Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Live Attenuated Polio Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Live Attenuated Polio Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Live Attenuated Polio Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Live Attenuated Polio Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Live Attenuated Polio Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Live Attenuated Polio Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Live Attenuated Polio Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Live Attenuated Polio Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Live Attenuated Polio Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Live Attenuated Polio Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Live Attenuated Polio Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Live Attenuated Polio Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Live Attenuated Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Live Attenuated Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Live Attenuated Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Live Attenuated Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Live Attenuated Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Live Attenuated Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Live Attenuated Polio Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Live Attenuated Polio Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Live Attenuated Polio Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Live Attenuated Polio Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Live Attenuated Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Live Attenuated Polio Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Introduction and Business Overview
Table 109. Sanofi Pasteur Live Attenuated Polio Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Pasteur Live Attenuated Polio Vaccine Product
Table 111. Sanofi Pasteur Recent Development
Table 112. GlaxoSmithKline Bio Company Information
Table 113. GlaxoSmithKline Bio Introduction and Business Overview
Table 114. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Product
Table 116. GlaxoSmithKline Bio Recent Development
Table 117. Bilthoven Bio Company Information
Table 118. Bilthoven Bio Introduction and Business Overview
Table 119. Bilthoven Bio Live Attenuated Polio Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Bilthoven Bio Live Attenuated Polio Vaccine Product
Table 121. Bilthoven Bio Recent Development
Table 122. Bharat Biotech Company Information
Table 123. Bharat Biotech Introduction and Business Overview
Table 124. Bharat Biotech Live Attenuated Polio Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Bharat Biotech Live Attenuated Polio Vaccine Product
Table 126. Bharat Biotech Recent Development
Table 127. Sinovac Biotech Company Information
Table 128. Sinovac Biotech Introduction and Business Overview
Table 129. Sinovac Biotech Live Attenuated Polio Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Sinovac Biotech Live Attenuated Polio Vaccine Product
Table 131. Sinovac Biotech Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Live Attenuated Polio Vaccine Market Trends
Table 135. Live Attenuated Polio Vaccine Market Drivers
Table 136. Live Attenuated Polio Vaccine Market Challenges
Table 137. Live Attenuated Polio Vaccine Market Restraints
Table 138. Live Attenuated Polio Vaccine Distributors List
Table 139. Live Attenuated Polio Vaccine Downstream Customers
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Live Attenuated Polio Vaccine Product Picture
Figure 2. Global Live Attenuated Polio Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Live Attenuated Polio Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Live Attenuated Polio Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Live Attenuated Vaccine
Figure 6. Global Live Attenuated Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Inactivated Vaccine
Figure 8. Global Inactivated Vaccine Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Live Attenuated Polio Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Live Attenuated Polio Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Live Attenuated Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Live Attenuated Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Live Attenuated Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Live Attenuated Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Live Attenuated Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Live Attenuated Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Live Attenuated Polio Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Live Attenuated Polio Vaccine Revenue in 2022
Figure 23. Live Attenuated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Health Center
Figure 29. Global Health Center Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Live Attenuated Polio Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Live Attenuated Polio Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Live Attenuated Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Live Attenuated Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Live Attenuated Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Live Attenuated Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Live Attenuated Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Live Attenuated Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Live Attenuated Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Live Attenuated Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Live Attenuated Polio Vaccine Manufacturing Cost Structure
Figure 45. Live Attenuated Polio Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed